Author

Yurim Seo

University of California, San FranciscoPrimary ORCID profile (0009-0002-1281-0919 · 2 papers)Unclaimed ORCID profile · follow to get notified of new preprints

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Same name, identified by ORCID

Yurim SeoiD2 papers · University of California, San Francisco

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 1 Approach:experimental assay· 1 Assay:metabolomics· 1 Organism:mouse· 1

Frequent Co-Authors

Abigail Krall· 1 shared Andrei GogaiD· 1 shared Brian N. FinckiD· 1 shared Heather Christofk· 1 shared Joyce V. Lee· 1 shared Longhui QiuiD· 1 shared Nedas MatulionisiD· 1 shared Robin K. Kelley· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

9 top collaborators · 36 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Abigail Krall

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Alanine Catabolism as a Targetable Vulnerability for MYC-Driven Liver Cancer

Tonatiuh Montoya, Joyce V. Lee, Longhui Qiu, Abigail Krall, Nedas Matulionis, Yurim Seo, Brian N. Finck, Robin K. Kelley, Heather Christofk, Andrei Goga

This study identifies GPT2-dependent alanine catabolism as a metabolic vulnerability in MYC-driven liver cancer, showing that inhibiting GPT2 reduces tumor growth in mouse models.

Cell Reports · Mar 17, 2026Peer-reviewedCancer Biology